Achieve Timely Market Access

PDCI works closely with manufacturers to minimize the time between NOC and public / private reimbursement. PDCI’s experience and long standing relationships with payers and HTA agencies helps navigate the procedural barriers, submission requirements, listing agreement negotiations and other challenges throughout the market access process. PDCI’s has experience with virtually all therapeutic classes (including oncology) and all technologies such as biologics, orphan drugs, medical devices and diagnostics. PDCI’s commitment to quality ensures that submissions are deemed complete in the first instance and our evidence-based approach offers the best opportunity for positive formulary listing decisions.

Our Services